Previous Article | Next Article ![]()
Appl. Environ. Microbiol., Apr 1997, 1307-1311, Vol 63, No. 4
TG Schimmel, WS Borneman and MJ Conder
An esterase from the fungus Clonostachys compactiuscula selectively
hydrolyzes lovastatin, a clinically useful antihypercholesterolemic agent.
Lovastatin or lovastatin-related compounds were required to induce the
activity of the lovastatin 8(prm1)-((alpha)-methylbutyryloxy) esterase. The
46-kDa esterase was purified from mycelial extracts by centrifugation and a
single anion-exchange chromatographic separation. Maximal lovastatin
esterase activity was found at pH 9.0 to 9.6 and at 25 to 30(deg)C. The
addition of 5 to 20% methanol resulted in greater lovastatin hydrolysis,
while the addition of other solvents (ethanol, isopropanol, butanol, ethyl
acetate, isopropyl acetate, or tetrahydrofuran) decreased hydrolysis.
Lovastatin was selectively hydrolyzed even in the presence of an excess of
simvastatin, another antihypercholesterolemic agent that is structurally
very similar to lovastatin. This lovastatin
8(prm1)-((alpha)-methylbutyryloxy) esterase can be used to prepare a core
intermediate for the generation of novel antihypercholesterolemic agents or
to purify simvastatin prepared by C methylation of the
2(S)-methylbutyryloxy side chain of lovastatin.
Copyright © 1997, American Society for Microbiology
Purification and Characterization of a Lovastatin Esterase from Clonostachys compactiuscula
Biotechnology Section, Technical Operations, Merck and Co., Inc., Elkton, Virginia 22827
This article has been cited by other articles:
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|